Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Internal Medicine
Institutions: Endeavor Health, University of Chicago, Eli Lilly (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409162613
